The man apparently experienced no adverse events attributable to vaccination and was immunologically no different from those who received three vaccine doses.
One author praised the roll-out of the COVID-19 vaccine as a model to be emulated, but a pharma expert warned against a risky technique used during the process.
The man apparently experienced no adverse events attributable to vaccination and was immunologically no different from those who received three vaccine doses.
One author praised the roll-out of the COVID-19 vaccine as a model to be emulated, but a pharma expert warned against a risky technique used during the process.